Leading CDMOs in Biologics, Cell & Gene, and Small Molecule share their current available capacity  – and associated capabilities, facility locations, and timelines – to help you identify options for your development and manufacturing needs.

June 7, 2022 | Large Molecule | Moderated by: Bikash Chatterjee, CEO of Pharmatech Associates

• Singota Solutions
• Thermo Fisher Scientific
• LucasPye BIO
• Cambrex
• Luina Bio

June 8, 2022 | Small Molecule | Moderated by: Joe Miller, CMC Consultant

• Cambrex
• Asymchem
• Singota Solutions
• Ascendia Pharmaceuticals
• Quotient Sciences

June 9, 2022 | Cell & Gene | Moderated by: Mark Sawicki, CEO of Cryoport

• Andelyn Biosciences
• IDT Biologika
• Cambrex
• Ascendia Pharmaceuticals
• LucasPye BIO
• AGC Biologics
• Oxford Biomedica

What can you expect? – Short, digestible presentations with live interaction to give you an inside look at the available capacity of industry suppliers. You will have the opportunity to ask questions of each CDMO to better understand if they can meet your needs – all from the convenience of your computer!

Find out more and register.